-
2021-03-21
db12ba1cf5127b1708b860e8842d84e2cc67ea69
/feed/2021/03/21/south-africa-concludes-the-sale-of-the-oxford-astrazeneca-vaccine-to-the-african-union-after-the-country-halted-its-use
South Africa concludes the sale of the Oxford-AstraZeneca vaccine to the African Union after the country halted its use after it was found to be not effective against 501.V2 variant.
1616372107
2021-03-21
8da20adacbd19d136ca9e27372848fdd648b4bad
32
African Union
71
/wiki/african%20union
AstraZeneca
14
/wiki/oxford-astrazeneca%20covid-19%20vaccine
COVID-19 pandemic
1
/wiki/covid-19%20pandemic
COVID-19 vaccine
37
/wiki/covid-19%20vaccine
South Africa
2
/wiki/south%20africa
African Union
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
South Africa
COVID-19 pandemic
2021-05-11
af6a5e8d9c361083cf9e25016d99a274f3efa85b
18
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/05/11/slovakia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-for-people-that-received-the-first-dose-after-the-state-inst
Slovakia suspends the use of the Oxford–AstraZeneca vaccine for people that received the first dose after the State Institute for Drug Control ruled that the death of a 47-year-old woman was likely connected to the jab.
2021-04-20
18b1398c40151edc934912804582c86ddce82674
/feed/2021/04/20/yemen-begins-their-covid-19-vaccination-campaign-by-using-the-vaccine-produced-by-astrazeneca-and-university-of-oxford
Yemen begins their COVID-19 vaccination campaign by using the vaccine produced by AstraZeneca and University of Oxford.
1618974429
2021-04-20
ac998792bf711d249f235cb22b7ddc7a1e88e0a7
17
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/04/20/yemen-begins-their-covid-19-vaccination-campaign-using-the-vaccine-produced-by-astrazeneca-and-the-university-of-oxford
Yemen begins their COVID-19 vaccination campaign using the vaccine produced by AstraZeneca and the University of Oxford.
2021-04-7
823afcc1d941c533623cd57d2b5417f7240dc24b
/feed/2021/04/7/belgium-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-55-years-old-following-a-report-f
Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.
1711505836
2021-04-7
45ee6be5348247cec19d4f9ff2d955ee92aa0036
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-by-people-under-60-years-old-following-a-report-of-a-possible
Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting.
1711505832
2021-04-7
c999b79831e13c0f740e79876ddfbe0820b206b7
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-60-years-old-following-a-report-of-a-possible
Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting.
1617987946
2021-04-7
68435713914e84303dcd86d56e76e393717f8d1a
/feed/2021/04/7/the-ministry-of-health-temporarily-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-follo
The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
1617858354
2021-04-7
31c5c63863486c5335de04767d7588ab718d3c0d
/feed/2021/04/7/estonia-suspends-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-report-of-possible-link
Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.
1617843950
2021-04-7
dd86b27e44dedfe2ca9f290b6d349f3765408b97
33
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/04/7/the-ministry-of-health-restricts-the-use-of-the-oxford-astrazeneca-vaccine-to-people-over-60-years-old-following-a-repor
The Ministry of Health restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
2021-03-27
71bac09c2f1de400347d587109cf571f2b473176
/feed/2021/03/27/bhutan-launches-their-largest-vaccination-campaign-against-covid-19-using-oxford-astrazeneca-vaccine-that-was-received-f
Bhutan launches their largest vaccination campaign against COVID-19 using Oxford-AstraZeneca vaccine that was received from India.
1616893580
2021-03-27
d1658f90569f57a4787fe99e4d50d1adbf9df17f
/feed/2021/03/27/bhutan-launches-the-largest-vaccination-campaign-covid-19-using-oxford-astrazeneca-vaccine-that-was-received-from-india
Bhutan launches the largest vaccination campaign COVID-19 using Oxford-AstraZeneca vaccine that was received from India.
1616857572
2021-03-27
8b1c10715e6542b8e89d133dfca79d7a7b2e48b7
16
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/03/27/bhutan-launches-their-largest-vaccination-campaign-against-covid-19-using-the-oxford-astrazeneca-vaccine-that-was-receiv
Bhutan launches their largest vaccination campaign against COVID-19 using the Oxford-AstraZeneca vaccine that was received from India.
2021-03-16
aeb30c56ec7a5488db861373a285674fd87164c3
/feed/2021/03/16/lithuania-suspends-the-use-of-the-oxford-astrazeneca-vaccine-as-precaution-following-three-reports-on-suspected-serious
Lithuania suspends the use of the Oxford-AstraZeneca vaccine as precaution following three reports on suspected serious adverse thromboembolic reaction among vaccinated people in the country.
1615950366
2021-03-16
b33c40e2646e15cc9eb13b3df759206e6f9cd1fb
12
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/03/16/lithuania-suspends-the-use-of-the-oxford-astrazeneca-vaccine-as-a-precaution-following-three-reports-of-suspected-seriou
Lithuania suspends the use of the Oxford-AstraZeneca vaccine as a precaution following three reports of suspected serious adverse thromboembolic reactions among vaccinated people in the country.
2021-02-11
32f4a3413ea16c9e919c64839f56b4f90023c6c1
/feed/2021/02/11/south-african-president-cyril-ramaphosa-announces-that-the-country-has-secured-nine-million-doses-of-johnson-johnson-s
South African President Cyril Ramaphosa announces that the country has secured nine million doses of Johnson & Johnson's vaccine, with the first shipment of 80,000 doses arriving next week.
1613120744
2021-02-11
cb884245a68d4fe9e3696d7fadb10fbbdb052f38
/feed/2021/02/11/south-african-president-cyril-ramaphosa-announces-that-the-country-has-secured-nine-million-doses-of-johnson-johnson-v
South African President Cyril Ramaphosa announces that the country has secured nine million doses of Johnson & Johnson vaccine, with the first batch of 80,000 will arrive next week.
1613091935
2021-02-11
d75b4ad0a8b9875b7d6d069527e04566c4cdafef
30
COVID-19 pandemic
COVID-19 vaccine
South Africa
3
/feed/2021/02/11/president-cyril-ramaphosa-announces-that-the-country-has-secured-nine-million-doses-of-johnson-johnson-s-vaccine-with
President Cyril Ramaphosa announces that the country has secured nine million doses of Johnson & Johnson's vaccine, with the first shipment of 80,000 doses arriving next week.
2021-02-7
d0a871de342406f5496d9381816b05f0514f4930
/feed/2021/02/7/south-africa-suspends-their-rollout-of-the-oxford-astrazenenca-vaccine-after-research-finds-that-the-vaccine-is-less-eff
South Africa suspends their rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
1612803928
2021-02-7
2b9e828e4bde64ff3dacf9eea9309515c02e0eae
/feed/2021/02/7/south-africa-suspends-the-rollout-of-oxford-astrazenenca-s-vaccine-after-the-research-finds-it-was-less-effective-agains
South Africa suspends the rollout of Oxford-AstraZenenca's vaccine after the research finds it was less effective against a 501.V2 variant discovered in the country.
1612746330
2021-02-7
ae28f9d61e1710e82397020d30e45bd99b53dd16
31
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
South Africa
4
/feed/2021/02/7/south-africa-suspends-its-rollout-of-the-oxford-astrazenenca-vaccine-after-research-finds-that-the-vaccine-is-less-effec
South Africa suspends its rollout of the Oxford-AstraZenenca vaccine after research finds that the vaccine is less effective against the 501.V2 variant discovered in the country.
2021-02-1
392515e1a9945f8e377785ccd2694632771975a6
/feed/2021/02/1/south-africa-receives-one-million-doses-of-oxford-astrazeneca-s-vaccine-produced-by-serum-institute-of-india-at-or-tam
South Africa receives one million doses of Oxford-AstraZeneca's vaccine produced by Serum Institute of India at O.R. Tambo International Airport.
1612235129
2021-02-1
96bffa721477b7f3d359d6107ce2884a0d8f061e
34
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
South Africa
4
/feed/2021/02/1/south-africa-receives-one-million-doses-of-the-oxford-astrazeneca-vaccine-produced-by-the-serum-institute-of-india
South Africa receives one million doses of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India.
2021-01-28
eb52b49550ecc37c468517bb5662762aafd4070c
/feed/2021/01/28/the-food-and-drug-administration-approves-oxford-astrazeneca-vaccine-for-emergency-use-in-the-philippines
The Food and Drug Administration approves Oxford-AstraZeneca vaccine for emergency use in the Philippines.
1611839163
2021-01-28
9744c55539c0270852031badd786f13e9e0ead95
41
AstraZeneca
COVID-19 pandemic
COVID-19 vaccine
3
/feed/2021/01/28/the-food-and-drug-administration-approves-the-oxford-astrazeneca-vaccine-for-emergency-use-in-the-philippines
The Food and Drug Administration approves the Oxford-AstraZeneca vaccine for emergency use in the Philippines.
2020-09-5
b890d001922845fa889a924930fa3633b72e5716
/feed/2020/09/5/south-africa-is-expected-to-begin-a-trail-of-the-nvx-cov2373-a-vaccine-candidate-produced-by-novavax-around-2904-volu
South Africa is expected to begin a trail of the NVX-CoV2373, a vaccine candidate produced by Novavax. Around 2,904 volunteers are expected to be selected, who are aged from 18 to 64 years.
1599325488
2020-09-5
706e4d0038918b4d34ed60be4a5383eebc5c8235
28
COVID-19 pandemic
COVID-19 vaccine
South Africa
3
/feed/2020/09/5/south-africa-is-expected-to-begin-a-trial-of-the-nvx-cov2373-a-vaccine-candidate-produced-by-novavax-around-2904-volu
South Africa is expected to begin a trial of the NVX-CoV2373, a vaccine candidate produced by Novavax. Around 2,904 volunteers are expected to be selected, who are aged from 18 to 64 years.
/feed/2021/03/21/south-africa-concludes-the-sale-of-their-oxford-astrazeneca-vaccines-to-the-african-union-after-the-country-stopped-usin
News24
21
6cbc23f2e4ca51d8c06d6d8ab275831a4105a0c0
3
https://www.news24.com/amp/news24/southafrica/news/covid-19-sale-of-astrazeneca-vaccine-to-au-concluded-health-minister-zweli-mkhize-20210321
2021
South Africa concludes the sale of their Oxford-AstraZeneca vaccines to the African Union after the country stopped using these vaccines because they were found to be not highly effective against the 501.V2 variant.